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INTRODUCTION
Prevalence of feline hyperthyroidism has increased over the last 30 years; the disease is currently a 
very common endocrinopathy of elderly cats (Peterson 
and Ward, 2007). Benign adenomas or adenomatous 
hyperplasia of the thyroid gland are documented 
as causes of the problem in 98% of the cases, while 
thyroid carcinomas are rare (Turrel et al., 1988; Naan 
et al., 2006). Diagnosis is considered to be straight-
forward in overt hyperthyroidism, but early or mild 
disease can pose diagnostic challenges, especially 
when a non-thyroid illness co-exists. History findings, 
epidemiological information, clinical examination 
and clinicopathological screening of patients can 
provide valuable indicators for diagnosis of the dis-
ease, although a definite diagnosis can be based only 
on thyroid hormone evaluation. Various treatment 
options exist and hyperthyroidism carries a favour-
able prognosis with early detection and appropriate 
therapy. Objective of this review is to describe the 
diagnostic approach and treatment options in feline 
hyperthyroidism.
HISTORY - EPIDEMIOLOGICAL INFORMA-
TION - CLINICAL SIGNS
The most common history findings, epidemio-
logical information and clinical signs related to cases 
of feline hyperthyroidism are summarised in Table 
1.
History
The reported median age of patients, at the 
time of diagnosis, is 12 to 13 years (range: 4-22 
years), with less than 5% of cases being younger 
than 8 years of age. No sex or breed of animals 
predisposition exists for development of the dis-
ease (Milner et al 2006). A progressive, mild to 
severe weight loss coupled with normal to increased 
appetite, is consistent with feline hyperthyroidism 
(Peterson et al., 1983; Broussard et al., 1995). 
Concurrent presence of polyphagia or normal appe-
tite and weight loss is a significant finding that limits 
differential diagnosis in thin cats (Gunn-Moore 
and Miller, 2006). Polyuria-polydipsia (PU/PD) is 
common and may often be the only presenting com-
plaint. Nevertheless, it must be kept in mind that in 
geriatric cats this is a primary sign of various system-
ic disorders (Mooney and Peterson, 2004).
Gastrointestinal manifestations of feline hyper-
thyroidism include intermittent vomiting, diarrhoea, 
increased volume and frequency of defaecations 
and steatorrhoea (Peterson et al., 1983; Thoday and 
Mooney, 1992). Behavioural changes are observed 
in up to 50% of cats, ranging from nervousness/rest-
lessness, to aggressive or frantic behaviour. Panting, 
respiratory distress, dermatologic problems and heat 
intolerance have also been reported (Feldman and 
Nelson, 2004).
A variant of feline hyperthyroidism is termed 
‘apathetic hyperthyroidism’, occurring in 5-20% of 
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2013). Hair coat is often unkempt, while alopecia 
and other dermatologic signs may be present as a 
consequence of overgrooming (Baral and Peterson, 
2012).
Palpable thyroid gland (goitre)
A palpable thyroid gland is present in over 90% 
of cases of feline hyperthyroidism (Peterson, 2013). 
Even though, thyroid size and total thyroxine blood 
concentration are related, it is now agreed that pres-
ence of goitre is a poor prognostic indicator for the 
disease (Ferguson and Freedman, 2006; Borreti et 
al., 2008). Several studies have demonstrated that 
thyroid enlargement may also exist in elder euthy-
roid cats. Some cats eventually develop hyperthy-
ness and lethargy are chief complaints, although a 
large period of polyphagia and weight loss precedes 
them (Thoday and Mooney, 1992; Bucknell, 2000). 
A severe non-thyroid illness, e.g. chronic kidney dis-
ease, congestive heart failure and neoplasia, usually 
co-exists. It is important for the clinician to investi-
gate thoroughly apathetic cases, as nature and sever-
ity of a concurrent disease will affect prognosis and 
therapeutic choices (Feldman and Nelson, 2004).
Clinical signs
General appearance
Hyperthyroid cats are in poor body condition, 
while muscle weakness with neck ventroflexion has 
also been described (Nemzek et al., 1994; Peterson, 
Table 1. Summary	presentation	of	history	details	and	clinical	signs	reported	to	be	associated	with	feline	hyperthyroidism	(compiled	
from	Feldman	and	Nelson	(2004),	Baral	and	Peterson	(2012),	Peterson	(2013)).
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 08/10/2019 04:42:48 |
J	HELLENIC	VET	MED	SOC	2013,	64(3)
ΠΕΚΕ	2013,	64(3)
stantial elevation of blood pressure is documented, 
potential occurrence of concurrent disease must be 
thoroughly investigated, especially of chronic kidney 
disease (Reusch and Scellenberg, 2010).
Stress intolerance
Stressful events can have adverse effects in 
hyperthyroid cats. Respiratory distress, cardiac 
arrhythmias and shock have all been identified in 
this context. It is important for a clinician to realise 
the fragility that accompanies the thyrotoxic state 
and handle accordingly these patients (Feldman and 
Nelson, 2004).
LABORATORY TESTS
Complete blood count, blood serum biochemi-
cal tests and urine testing are useful in supporting 
diagnosis, eliminating other diseases with similar 
clinical signs and investigating the presence of con-
current non-thyroid illnesses.
Complete blood count
Haematologic changes are usually mild and of 
no clinical significance. Erythrocytosis, macrocy-
tosis and increased numbers of Heinz bodies have 
been described. Increased number of neutrophils or 
increased lymphocyte and eosinophil numbers can 
be expected as leucocyte changes (Peterson et al., 
1983).
Blood biochemical tests
Increased activity of alkaline phosphatase and 
alanino-aminotransferase are described in over 
90% of cases (Broussard et al., 1995), correlat-
ing well with total thyroxine blood concentration. 
Nonetheless, no hepatic parenchymal or functional 
abnormalities are noted and liver enzyme activ-
ity becomes normal after induction of euthyroidism 
(Berent et al., 2007). When marked increases in liver 
enzyme activity occur in mildly hyperthyroid cats, an 
investigation for liver disease must be pursued, espe-
cially when they persist despite treatment. As bile 
acids are not affected, their measurement is consid-
ered very useful in differentiating hyperthyroidism 
from primary liver disease (Foster and Mooney 
2000). 
Hyperphosphataemia, in the absence of azo-
roidism, indicating that a subclinical hyperthyroid 
state exists (Norsworthy et al., 2002a; 2002b). Other 
possibilities in the differential diagnosis for a feline 
cervical mass include non-functional thyroid and 
parathyroid cysts, adenomatous parathyroid hyper-
plasia, lymphoid neoplasia, salivary mucocoele and 
dermoid cysts (Norsworthy et al., 2002a; Phillips et 
al., 2003; Tolbert et al., 2009). In conclusion, even 
though goitre increases the likelihood of hyperthy-
roidism, it does not precisely reflect the functional 
status of the gland. When present in a euthyroid cat, 
a periodical evaluation of thyroid status should be 
undertaken (Norsworthy, 2002b).
Cardiovascular manifestations
Tachycardia (>240 beats min-1) and a powerful 
apex beat are frequently recorded in feline hyper-
thyroidism. Systolic murmurs, grade I-III/VI, the 
intensity of which varies with heart rate and gallop 
rhythm, attributed to dynamic left or right ventricu-
lar outflow tract obstruction and rapid ventricular 
filling respectively, are often auscultated (Broussard 
et al., 1995; Rishniw and Thomas, 2002; Peterson, 
2013).
In contrast to earlier reports, feline hyperthy-
roidism is now considered to be a rare cause of 
congestive heart failure. The prevalence of conges-
tive heart failure in hyperthyroidism ranges from 
2% to 3%, in most cases reflecting decompensation 
of subclinical heart disease, due to the increased 
circulating blood volume of the thyrotoxic state 
(Syme, 2007). Left-sided cardiomegaly, left ventricu-
lar hypertrophy, left atrial and ventricular dilation 
and increased fraction shortening are common, but 
subtle and clinically insignificant (Bond et al., 1988, 
Fox et al., 1999; Connolly et al., 2005). Also, thyroid 
hyperactivity has a modest but significant effect 
on circulating natriuretic peptide, which should be 
taken into account when evaluating elderly cats for 
primary myocardial disease (Menaut et al., 2012).
Hypertension was cited as a common sequel of 
hyperthyroidism in older studies (Kobayasi et al., 
1990). Today its prevalence is thought to be low and 
is accepted that false positive results are common 
due to a susceptibility of hyperthyroid cats to the 
so-termed ‘white coat effect’. Hypertension, when 
present, is mild to moderate and asymptomatic 
(Sartor et al., 2004; Henik et a., 2008). When sub-
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taemia, is reported in 20-43% of hyperthyroid cats 
(Shiel and Mooney, 2007). Also, ionised calcium 
and parathormone concentrations were found to 
decrease and increase, respectively, in a significant 
number of cats in two studies. These findings indi-
cate that hyperparathyroidism is common in hyper-
thyroidism, even though it may not be clinically 
significant (Archer and Taylor, 1996; Barber and 
Elliot, 1996). Azotaemia is present in about 10% of 
the cases; an expected finding since chronic kidney 
disease is also common in elderly cats (Broussard 
et al., 1995; Plantiga et al., 2005). Less commonly, 
potassium coagulation parametres, serum folate and 
cobalamin may be affected (Randolph et al., 2006; 
Milner et al., 2006; Cook et al., 2011).
Urine testing
Results of routine urine testing, in general, do 
not provide significant results. Urine specific gravity 
has a significant variation with values ranging from 
1009 to 1050 (Broussard et al., 1995). Proteinuria 
that decreases after therapy institution, is document-
ed in 30% of animals, but is yet of unknown clinical 
significance (van Hoek et al., 2009a). Urinary tract 
infections with no abnormalities suggestive of lower 
urinary tract disease, can occur in up to 12% of 
patients, hence bacteriological examination is rec-
ommended in all cats with hyperthyroidism (Mayer-
Roenne et al., 2006).
TESTS FOR DEFINITE DIAGNOSIS OF THE 
DISEASE
Measurement of total thyroxine blood concentra-
tion
Increased total thyroxine blood concentration 
is a very specific finding, occurring in up to 90% 
of hyperthyroid cats and is the preferred screening 
test for feline hyperthyroidism (Peterson, 2013). 
However, it is now accepted that, overall, 10% 
of animals with clinical signs and 40% of animals 
with subclinical or mild disease have normal total 
thyroxine blood concentrations (Peterson et al., 
2001). Concurrent presence of a non-thyroid ill-
ness and thyroid hormones fluctuation are the pro-
posed explanations. False-negative results can be 
observed in mild cases of the disease, in which total 
thyroxine blood concentration can be found to be 
within the middle to high-end of the reference range. 
This effect is of no diagnostic significance in overt 
disease, in which severe increases in total thyrox-
ine blood concentration occur (Shiel and Mooney, 
2007).
Concurrent non-thyroid illness is identified in 
up to 30% of hyperthyroid cats with the total thyrox-
ine blood concentration being within the normal ref-
erence range. Even though the mechanisms involved 
are not clearly defined, the lowering effect appears 
to correlate with the severity and not the type of the 
disease, with lowest concentrations occurring in the 
animals with most serious clinical signs (McLouglin 
et al., 1993; Peterson et al., 2001). Fluctuation of 
thyroid hormones has been demonstrated by serial 
measurements of total thyroxine blood concentra-
tions in mildly hyperthyroid cats during a 15 day 
period (Peterson et al., 1987).
Measurement of free thyroxine blood concentration
Free thyroxine is the non-protein bound frac-
tion of thyroxine and is responsible for its biologic 
effect. Free thyroxine is increased in approximately 
98% of hyperthyroid cats, including 95% of the 
animals in which total thyroxine blood concentra-
tion is within the reference range (Peterson et al., 
2001). However, free thyroxine cannot be used as a 
screening tool for feline hyperthyroidism, since it is 
also found increased n 6 to 31% of euthyroid cats. 
Another disadvantage in measuring free thyroxine 
blood concentration is that valid measurements can 
only be obtained by equilibrium dialysis, an expen-
sive and not widely available technique (Mooney 
et al., 1996; Peterson et al., 2001; Wakeling, 2008). 
Free thyroxine blood concentration must always be 
interpreted in the context of total thyroxine blood 
concentration and cannot be used as the sole means 
for diagnosis. Increased free thyroxine blood concen-
tration, coupled with middle to high reference range 
total thyroxine blood concentration is suggestive 
of hyperthyroidism, while increased free thyroxine 
blood concentration with a decreased total thyroxine 
concentration is usually associated with non-thyroid 
illness. As increases in total thyroxine blood concen-
tration are always accompanied by increases in free 
thyroxine blood concentration, measurement of both 
in overt hyperthyroidism is of no diagnostic impor-
tance (Feldman and Nelson, 2004).
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uptake or increased salivary to thyroid gland ratio 
are used and both indices correlate very well with 
total thyroxine blood concentration. Scintigraphy is 
not influenced by non-thyroid illness and can also 
detect mild cases of hyperthyroidism and ectopic 
thyroid tissue. On the other hand, the need for 
sophisticated equipment and skilled personnel, as 
well as its high cost make it largely unavailable 
(Freeney and Anderson, 2007; Harvey et al., 2008).
Dynamic thyroid function tests
Dynamic thyroid function tests are nowadays 
obsolete, as measurement of total thyroxine and free 
thyroxine blood concentration along with scintigra-
phy are adequate in reaching a diagnosis in practi-
cally all cats under investigation. Their use must 
be considered only in animals, in which repeated 
measurements of total thyroxine blood concen-
tration are unrewarding and free thyroxine blood 
concentration or scintigraphy cannot be performed 
(Peterson, 2013). Details of these tests are summa-
rised in Table 2.
Feline thyroid stimulating hormone
Measurement of thyroid stimulating hormone 
(TSH) is considered to be a first line diagnostic test 
for hyperthyroidism in human medicine, because 
it is suppressed even in mild cases and is not influ-
enced by concurrent disease (Shiel and Mooney, 
2007). No commercially available assays specifically 
for cats are currently available. A canine first-gener-
ation assay has been used with controversial results. 
Even though canine thyroid stimulating hormone 
has a 96% homology with the hormone in cats, a 
distinction between normal and undetectable values 
was not found to be always reliable. Today, the value 
of thyroid stimulating hormone is limited to the 
exclusion of the disease when a detectable concen-
tration is measured (Wakeling et al., 2008, Rutland 
et al., 2009).
Scintigraphy
Thyroid scintigraphy is based on the increased 
uptake of radionine isotopes (131I, 123I) and tech-
netium by the diseased thyroid gland. Proportion 
Table 2. Summary	of	details	of	dynamic	thyroid	function	tests	that	may	be	performed	in	cats	(Shiel	and	Mooney,	2007).
206	 	 	 	 					KASABALIS	D.,	SOuBASIS	N.,	PETANIDES	T.A.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 08/10/2019 04:42:48 |
J	HELLENIC	VET	MED	SOC	2013,	64(3)
ΠΕΚΕ	2013,	64(3)
be useless, as they are encountered in both diseases 
(Graves, 2010). It has been suggested that chronic 
kidney disease is likely in hyperthyroid patients 
with small and irregular kidneys or when high-nor-
mal creatinine concentrations are accompanied by 
extreme increases in total thyroxine blood concen-
tration (Syme, 2007). On the other hand, hyper-
thyroidism must be suspected when polyphagia or 
normalization of azotaemia is observed in cats that 
had been previously diagnosed with chronic kidney 
disease (Feldman and Nelson, 2004).
Diabetes mellitus
Previous studies have documented that approx-
imately 6% of diabetic cats develop hyperthyroidism 
and vice-versa (McLoughlin et al., 1993; Crenshaw 
and Peterson, 1996). Moreover, these were the most 
common endocrinopathies occurring concurrently 
in a retrospective study of feline multiple endocrine 
diseases and accounted for 77% of all cases (Blois 
et al., 2010). Besides the clinical similarities, several 
confounding factors make diagnosis difficult when 
both diseases develop. Presence of a total thyroxine 
blood concentration within the reference range in 
a diabetic cat cannot rule out hyperthyroidism, as 
previously discussed. On the other hand, hyperthy-
roidism results in a decrease of serum fructosamine, 
because of accelerated protein turnover and it can-
not be used for diagnostic or monitoring purposes 
in the diabetic cat (Graham et al., 1999; Reusch and 
Tomsa, 1999). Regarding treatment, occurrence of 
hyperthyroidism in a well-controlled diabetic cat 
results in deterioration of glycaemic control and 
increase in insulin needs. Treatment of the dis-
ease improves insulin resistance and dose must be 
reduced accordingly to avoid hypoglycemia (Hoenig, 
2012).
TREATMENT OF THE DISEASE
Treatment options in feline hyperthyroidism 
include medical management, thyroidectomy, radio-
active iodine (I131) administration and nutritional 
therapy, all these alone or in conjunction with each 
other. Each option has advantages and disadvan-
tages that must be taken into consideration when 
deciding a therapeutic strategy (Table 3).
HYPERTHYROID CATS WITH TOTAL 
THYROXINE BLOOD CONCENTRATION 
WITHIN THE REFERENCE RANGE
Clinicians should always investigate thoroughly 
for presence of a non-thyroid illness, in cases in 
which hyperthyroidism is a primary component in 
the differential diagnosis, but total thyroxine blood 
concentration remains within the reference range. 
Middle to high reference range total thyroxine blood 
concentrations values in a sick cat are highly sug-
gestive for hyperthyroidism, as thyroid hormones 
decline in sick euthyroid cats. In the absence of 
overt disease, measurement of total thyroxine blood 
concentration can be performed again after two 
to six weeks, as, in most cases, it would eventually 
revert outside the reference range. Measurement of 
free thyroxine blood concentration is also a viable 
option in both cases, due to its high sensitivity. 
Infrequently, when repeated measurements of thy-
roxine and free thyroxine blood concentration fail 
to demonstrate hyperthyroidism or measurement of 
free thyroxine blood concentration is unavailable, 
scintigraphy and dynamic thyroid tests can be used 
for further investigation (Shiel and Mooney, 2007).
HYPERTHYROIDISM AND CONCURRENT 
DISEASE
Chronic kidney disease
Hyperthyroidism and chronic kidney disease 
are both commonly encountered in geriatric cats 
and their co-existence can present a diagnostic chal-
lenge (Lurye, 2006; Plantiga et al., 2005). Chronic 
kidney disease has a suppressive effect on total 
thyroxine blood concentration. Moreover, it is estab-
lished that free thyroxine blood concentration is 
markedly influenced, with false-positive results 
being common (Wakeling et al., 2008). Chronic kid-
ney disease is also largely underestimated in hyper-
thyroid patients. Creatinine concentration decreases 
in the thyrotoxic state, due to the increased glomer-
ular filtration rate and reduction of total muscle 
mass. Blood urea nitrogen can be decreased or 
elevated, as a consequence of increased glomeru-
lar filtration rate or increased protein catabolism, 
respectively (Syme, 2007). Other clinical and clin-
icopathological hallmarks of chronic kidney disease, 
e.g. polyuria/polydipsia and hyposthenuria, may also 
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A recent study showed that glomerular filtra-
tion rate markedly declines during the first month 
after induction of euthyroidism and it remains rela-
tively stable the following five to six months (van 
Hoek et al. 2009a). Therefore, if azotaemia does 
not develop after a month of reaching euthyroidism, 
more permanent means of therapy can be pursued. 
It must be kept in mind though, that no studies 
could be found to evaluate this hypothesis and it is 
possible that, in a given patient, azotaemia can occur 
after thyroidectomy or radionine therapy, even if the 
animal was found to be non-azotaemic during the 
therapeutic trial period (Trepanier, 2007).
Medical management
The use of antithyroid medication is a valid 
treatment modality with high efficacy and low cost. 
It can be used for long term management, as a 
means to assess renal function and for improv-
Treatment and renal function (‘the methimazole 
trial’)
Feline hyperthyroidism improves clinical signs 
and biochemical manifestations of chronic kidney 
disease through increases in glomerular filtration 
rate. Approximately 20-25% of feline hyperthy-
roidism cases without known chronic kidney disease 
will develop azotaemia, regardless of therapeutic 
modality, as a result of decline of glomerular filtra-
tion rate (Graves, 2010). Increases in serum cre-
atinine concentrations occur in 15-50% of cats after 
treatment (Adams et al., 1997; Becker et al., 2000,; 
Slater et al., 2001; Williams et al., 2010). Evaluation 
of various parametres (urine specific gravity, blood 
urea nitrogen, creatinine concentration) before 
treatment are not useful in predicting potential 
development of post-treatment azotaemia (Riensce 
et al., 2008). In order to have a ‘preview’ of renal 
function in hyperthyroid cats, a therapeutic trial with 
a reversible form of treatment (e.g., methimazole) is 
Table 3.	Summary	comments	of	major	therapeutic	approaches	in	feline	hyperthyroidism	(Trepanier,	2007;	Peterson,	2013).
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ing conditions related to hyperthyroidism before 
thyroidectomy or radionine therapy. On the other 
hand, it is not a permanent treatment; it requires 
life-long medication, with increased owner and ani-
mal compliance, and has side effects (Feldman and 
Nelson, 2004). Drugs currently used in this approach 
are methimazole and carbimazole.
Methimazole
The efficacy of methimazole is >90%, when 
side effects do not occur. The drug blocks synthesis 
of thyroid hormones by inhibiting the organifica-
tion of iodide and the coupling of iodio-thyronines 
to form thyroid hormones. As it does not inhib-
it release of the stored thyroid hormones, two to 
four weeks are needed before total thyroxine blood 
concentration comes within the reference range 
(Peterson et al., 1988). Goitre size is not expected to 
be reduced with medical treatment. Recommended 
starting dose of methimazole is 2.5-5 mg daily, 
administered in two equal doses. Other schemes, 
with increased (up to 15 mg daily) and more fre-
quent dosing are described in the literature, but they 
are not needed and would probably increase the risk 
of renal decompensation and potential side effects. 
Also, once daily administration has been shown to 
be ineffective and it is not recommended. Symptoms 
begin to resolve two to six weeks after return to nor-
mal of total thyroxine blood concentration. If the 
response is not adequate, up titration of the dose 
can be made (Trepanier et al., 2003; Trepanier, 
2007).
Adverse reactions occur in up to 18% of cats 
usually within the first three months of treatment 
(Peterson et al., 1988). Vomiting, anorexia and 
lethargy are common, transient and respond to 
dose reduction (Peterson, 2013). Neutropaenia and 
thrombocytopaenia are documented in 3 to 9% 
of cats, whilst aplastic anemia has also been rarely 
described. Blood dyscrasias resolve one week after 
discontinuation of methimazole, but may reoccur 
with re-challenge, making drug withdrawal neces-
sary. Face and neck excoriations, hepatotoxicity, 
coagulation abnormalities and acquired myasthe-
nia gravis are less commonly observed (3% of 
treated cats) and also require drug discontinuation 
(Peterson et al., 1988; Sartor et al., 2004; Weiss, 
2006).
A formulation for transdermal administration 
of the drug, compounded in pluronic lecithin orga-
nogel, is also available. Its efficacy is documented 
to be smaller in comparison to oral administration. 
Also, no differences were observed regarding side-
effects, besides gastrointestinal disturbances, which 
were decreased with the trandermal formulation. 
Nonetheless, it is a therapeutic alternative, especially 
when pill administration is difficult (Sartor et al., 
2004).
Monitoring is extremely important in ensuring 
response to treatment and detecting side effects. 
It begins after two to three weeks and includes 
measurement of a complete blood count, alkaline 
phosphatase, alanino-aminotransferase, blood urea 
nitrogen concentration and creatinine concentra-
tion, along with total thyroxine blood concentrations 
(Trepanier, 2007). Timing of blood sampling is not a 
significant factor for total thyroxine blood concentra-
tion measurement (Rutland et al., 2009; Borreti et 
al., 2013). If side effects are noted, the drug should 
be discontinued and another therapeutic option 
should be pursued (Luyre, 2006).
The goal for total thyroxine blood concentration 
is to remain in the lower part of the reference range. 
When increased concentrations occur, the dose can 
be increased to 2.5 to 5 mg daily and blood concen-
trations of thyroid hormones are re-evaluated four 
weeks later. In the long term, the goal is to find the 
lower dose that keeps total thyroxine blood concen-
tration within the reference range and the cat free 
of clinical signs with no adverse reactions. After the 
initial period, total thyroxine blood concentration, 
complete blood count and biochemical monitor-
ing should be repeated every three to six months 
(Peterson, 2013).
Carbimazole
Carbimazole is found to be effective when 
administered at an initial dose of 2.5 to 5 mg daily, 
divided in two to three doses. The lower range is 
preferred initially and dose escalation can be made, 
based on total thyroxine blood concentration meas-
urement. A sustained release formulation of carbi-
mazole also exists that is efficient when given once 
daily (Frenais et al., 2009). Even though vomit-
ing and anorexia are less commonly observed than 
methimazole, there are no studies comparing the 
adverse reactions of the two drugs. Since methi-
mazole is a derivative of carbimazole, carbimazole 
administration is not advised if methimazole-associ-
ated adverse reactions develop (Trepanier, 2007).
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As mentioned earlier, some cats will develop 
post-treatment azotaemia. In these patients, the goal 
to maintain euthyroidism with no signs of uraemia is 
not always feasible. Treatment should be tailored to 
the individual patient and no established formula or 
data exist to support recommendations. Clinicians 
must decide whether to allow a cat to remain thy-
rotoxic, in order to preserve glomerular filtration 
rate or not, depending on severity of clinical signs. 
Interestingly, a recent study in a large population 
of hyperthyroid cats concluded that development of 
azotaemia post-treatment did not significantly influ-
ence survival of the patients (Wakeling et al., 2006; 
Williams, 2010).
TREATMENT OF A NEWLY DIAGNOSED 
HYPERTHYROID CAT WITH PRE-EXISTING 
ΑΖΟΤΑΕΜΙΑ
It is important to understand that presence of 
chronic kidney disease does not exclude treatment 
for hyperthyroidism. On the contrary, recent evi-
dence suggests that hyperthyroidism contributes to 
development and further progression of chronic kid-
ney disease with detrimental implications for kidney 
function in cats with untreated or poorly regulated 
hyperthyroidism (van Hoek et al., 2009b). Medical, 
and perhaps nutritional, management is the only 
viable choice in such animals. Drugs must be intro-
duced gradually at a low starting dose (1.25 mg, 
once daily) and up-titrated with caution. Inevitably, 
glomerular filtration rate would decline and chronic 
kidney disease symptoms will worsen. Subsequent 
management should be based on clinical response 
and serum creatinine and blood urea nitrogen con-
centrations, not on total thyroxine blood concen-
tration, which is unreliable unless it is markedly 
increased.
Concurrent management of chronic renal fail-
ure is also extremely important. Prognosis of hyper-
thyroid cats with chronic renal failure is guard-
ed to poor, especially when euthyroidism cannot 
be achieved. In such cases, median survival times 
reported are approximately 6 months (Syme, 2007; 
Peterson, 2013).
CONCLUDING REMARKS
Hyperthyroidism is commonly observed in geri-
Thyroidectomy
Throidectomy is a highly efficient treatment 
procedure, in the absence of radionine therapy con-
sidered to be the treatment of choice. However, 
it is accompanied with increased morbidity and 
mortality, in overt hyperthyroidism. Pre-operative 
management with anti-thyroid medication is advised 
to minimise anaesthetic and surgical complications. 
Surgery can be pursued after euthyroidism has been 
achieved for one to three weeks. If anti-thyroid 
medications are not tolerated, nutritional therapy or 
β-blockers (atenolol, propranolol) can be used for 
pre-operative preparation. Post-operative complica-
tions include iatrogenic hypoparathyroidism, laryn-
geal paralysis and oedema, Horner’s syndrome and 
haemorrhage (Naan et al., 2006). Relapses, although 
uncommon, occur due to poor technique or ectopic 
thyroid tissue. Total thyroxine blood concentration 
should be monitored thereafter once or twice a year 
(Peterson, 2013).
Radionine therapy
Radioactive iodine therapy (I131) is the treat-
ment of choice for hyperthyroidism. A single ses-
sion restores euthyroidism in 95% of cats, while the 
remaining will respond to a second session. Adverse 
reactions are rare, but a pre-treatment period with 
methimazole is considered mandatory. Regardless 
of the high-efficacy, the need for special facilities 
and skilled personnel coupled with the high cost 
makes the procedure of limited availability (Baral 
and Peterson, 2012).
Reduced iodine diet
Recent studies have concluded that a reduced 
iodine, commercially available diet led to induc-
tion of euthyroidism in a cohort of cats within four 
to twelve weeks. Even though further research is 
needed to evaluate safety and efficacy of reduced-
iodine diets, indications for their use include cats 
that cannot tolerate oral medication and are not 
appropriate candidates for more permanent treat-
ment modalities. Nevertheless, the approach is not 
curative and requires life-long and exclusive admin-
istration; moreover, high carbohydrate, relatively 
low-protein composition of such diets would not be 
ideal for elderly hyperthyroid cats with muscle wast-
ing (Melandez et al., 2011; Yu et al., 2011; Peterson, 
2013).
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therapeutic measures with good results. Close moni-
toring is essential to achieve a favourable outcome.
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atric cats with a good long term prognosis. A thor-
ough search for historical and clinical evidence of 
the disease provides valuable information. The diag-
nosis is ultimately based on documenting increased 
blood concentrations of thyroid hormones.
Concurrent non-thyroid illness must be exclud-
ed in a diligent manner, as they affect diagnosis and 
treatment options. Medical management, surgery, 
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